Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease

Nature Medicine

Volumn 8, Issue 6, 2002, Pages 600-606

  Xu, Jin ^a   Kao, Shyan Yuan ^a   Lee, Frank J S ^a   Song, Weihong ^a   Jin, Lee Way ^b   Yankner, Bruce A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL LOSS; COMPLEX FORMATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

14-3-3 PROTEINS; ALPHA-SYNUCLEIN; APOPTOSIS; CELLS, CULTURED; DOPAMINE; HUMANS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PARKINSON DISEASE; PHOSPHOPROTEINS; SUBSTANTIA NIGRA; SYNUCLEINS; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE;

EID: 0036278335     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0602-600     Document Type: Article

References (30)

1. α-synuclein in Lewy bodies
2. Etiology and pathogenesis of Parkinson's disease
3. Mutation in the α-Synuclein gene identified in families with Parkinson's disease
4. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
5. Wild-type but not Parkinson's disease-related ala-53→Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli
6. α-synuclein shares physical and functional homology with 14-3-3 proteins
7. Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity
8. Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells
9. A Drosophila model of Parkinson's disease
10. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
11. Parkinson-like neurodegeneration induced by targeted overexpression of α-synuclein in the nigrostriatal system
12. α-synuclein promotes mitochondrial deficit and oxidative stress
13. Human α-Synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine
14. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
15. Ubiquitination of a new form of α-synuclein by parkin from human brain: Implications for Parkinson's disease
16. β-synuclein inhibits α-synuclein aggregation: A possible role as an anti-parkinsonian factor
17. α-synuclein affects the MAPK pathway and accelerates cell death
18. 14-3-3 Proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains
19. Apoptosis in the nervous system
20. Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
21. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
22. Glutathione is involved in the granular storage of dopamine in rat PC12 pheochromocytoma cells: Implications for the pathogenesis of Parkinson's disease
23. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
24. The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies in Parkinson's disease
25. Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture
26. Acceleration of oligomerization, not fibrillization, is a shared parperty of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
27. Contribution of somal Lewy bodies to neuronal death
28. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
29. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
30. Selection of neuroblastoma cells that synthesize certain transmitters